WNT7B and breast cancer: The BL2 subtype is mainly defined by the abnormal over-activation of several signalling pathways such as Wnt/β-catenin; indeed, one of the overexpressed genes found in our study is WNT7B, also reported by several studies in governing BC generally and TNBC more specifically [33].